| 000 | 01772 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518003346.0 | ||
| 264 | 0 | _c20190514 | |
| 008 | 201905s 0 0 eng d | ||
| 022 | _a1090-2104 | ||
| 024 | 7 |
_a10.1016/j.bbrc.2018.10.029 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBardet, Maureen | |
| 245 | 0 | 0 |
_aMALT1 activation by TRAF6 needs neither BCL10 nor CARD11. _h[electronic resource] |
| 260 |
_bBiochemical and biophysical research communications _c11 2018 |
||
| 300 |
_a48-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aB-Cell CLL-Lymphoma 10 Protein _xdeficiency |
| 650 | 0 | 4 |
_aCARD Signaling Adaptor Proteins _xdeficiency |
| 650 | 0 | 4 | _aCRISPR-Cas Systems |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 |
_aGene Editing _xmethods |
| 650 | 0 | 4 | _aGene Expression Profiling |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 |
_aGuanylate Cyclase _xdeficiency |
| 650 | 0 | 4 | _aHEK293 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntracellular Signaling Peptides and Proteins |
| 650 | 0 | 4 | _aJurkat Cells |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 |
_aMucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein _xgenetics |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aTNF Receptor-Associated Factor 6 _xgenetics |
| 650 | 0 | 4 |
_aTetradecanoylphorbol Acetate _xpharmacology |
| 700 | 1 | _aSeeholzer, Thomas | |
| 700 | 1 | _aUnterreiner, Adeline | |
| 700 | 1 | _aWoods, Simone | |
| 700 | 1 | _aKrappmann, Daniel | |
| 700 | 1 | _aBornancin, Frédéric | |
| 773 | 0 |
_tBiochemical and biophysical research communications _gvol. 506 _gno. 1 _gp. 48-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbrc.2018.10.029 _zAvailable from publisher's website |
| 999 |
_c28954628 _d28954628 |
||